Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 145.26

-1.1%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Billy Dunn who wrote ()	8/29/1997 4:45:00 PM
From: Xavier	of 1834

Profi: I just talked with Mr. Lyons at Neurocrine Bios. He said that the stock price is basically suffering from weakness in the Biotech companies due to less-than-positive news in regards to clinical trials. He also said that he expects fourth quarter to be busier and have more announcements, but none too earth shaking. He also said that they recently picked up a few more analysts who are recommending the stock. You might want to keep an eye out and look to get back in a few months from now. good luck!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next